UCSF Secures $100 Million to Enhance Dementia Research and Care
UC San Francisco (UCSF) recently announced a monumental $100 million donation to enhance its Memory and Aging Center (MAC). This gift marks the first time a UCSF division has been named, now officially designated as the Edward and Pearl Fein Memory and Aging Center.
Dementia Research and Care Support
The significant contribution comes from the Edward Fein Charitable Trust. UCSF Chancellor Sam Hawgood emphasized the urgency in addressing neurodegenerative diseases, particularly Alzheimer’s, highlighting the need for advanced research, education, and better care for dementia patients.
- Donation: $100 million
- New Division Name: Edward and Pearl Fein Memory and Aging Center
- Key Focus: Alzheimer’s and other neurodegenerative diseases
Legacy of Philanthropy
Edward Fein, a native of Brooklyn, New York, was a stockbroker who retired in 1972. Recognizing the exceptional care he received at UCSF, Fein, alongside his wife Pearl, aimed to leave a robust legacy in dementia research and care.
The Fein MAC, part of the UCSF Weill Institute for Neurosciences, has significantly contributed to advancements in Alzheimer’s diagnostics and treatments. Their scientists are currently leading numerous national trials and innovations in patient care.
Innovative Research Initiatives
One noteworthy discovery by Dr. Bruce Miller, the Fein MAC’s founding director, revealed that frontotemporal dementia can sometimes trigger hidden artistic talents in patients. This intriguing insight has spurred further research on the connection between personality changes and creativity in dementia patients.
Miller noted the strength of the Fein MAC lies in the collaboration between clinical practitioners and research scientists. Observations from patient care often inspire new research initiatives.
Global Outreach and Education
The Fein MAC is also committed to global knowledge sharing. It provides educational programs for a wide range of professionals, including physicians, nurses, and therapists, along with a visiting artist program and initiatives through the Global Brain Health Institute.
- Training Offered: Physicians, nurses, psychologists, and social workers
- Community Engagement: Extensive outreach and postdoctoral training
The increasing prevalence of dementia worldwide demands a concerted global response. By 2050, projections estimate that 150 million people globally will be living with dementia. The Fein MAC’s leadership, including Dr. Gil Rabinovici, aims to improve patient care through advanced brain imaging and innovative treatment developments.
Dr. Rabinovici expressed gratitude for the Fein family’s longstanding support, which has been instrumental since 2015. This recent contribution is expected to ensure that the vital work at the Edward and Pearl Fein Memory and Aging Center will continue for future generations.
